Literature DB >> 29211255

Severe functional difficulties and disabilities in children and adolescents and the Sustainable Development Goals.

Filipa de Castro1, Celia Hubert2,1, Erika Strand3, Eva Prado3, Ariela Braverman1.   

Abstract

OBJECTIVE: To report prevalence of severe child functional difficulties and disability (CFD) in a nationally representative sample of 2 to 17 year-old children in Mexico and describe the inequities faced by children with CFD in relation to a set of Sustainable Development Goals (SDG)-related outcomes.
MATERIALS AND METHODS: Using data from the National Survey of Children and Women (ENIM 2015) we estimate prevalence with 95% confidence intervals for the selected indicators. We use chi-square test and confidence intervals inspection to report significant differences between children with and without CFD.
RESULTS: 8% of children present at least one CFD. CFD is associated with higher prevalence of underweight and child labor and lower prevalence of adequate early child development. Conclusion. Children with CFD present worst outcomes and require targeted efforts to ensure they meet health and wellbeing targets in the frame of the SDGs.

Entities:  

Mesh:

Year:  2017        PMID: 29211255     DOI: 10.21149/8487

Source DB:  PubMed          Journal:  Salud Publica Mex        ISSN: 0036-3634


  2 in total

1.  The impact of maternal health care utilisation on routine immunisation coverage of children in Nigeria: a cross-sectional study.

Authors:  Onyekachi Ibenelo Anichukwu; Benedict Oppong Asamoah
Journal:  BMJ Open       Date:  2019-06-19       Impact factor: 2.692

2.  Out-of-pocket expenditures and care time for children with Down Syndrome: A single-hospital study in Mexico City.

Authors:  Silvia Martínez-Valverde; Guillermo Salinas-Escudero; Constanza García-Delgado; Juan Garduño-Espinosa; Verónica F Morán-Barroso; Víctor Granados-García; Ma Teresa Tiro-Sánchez; Filiberto Toledano-Toledano; Ma Vanessa Aldaz-Rodríguez
Journal:  PLoS One       Date:  2019-01-10       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.